Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction
- 1 October 1988
- journal article
- conference paper
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 16 (5) , 529-542
- https://doi.org/10.1007/bf01062383
Abstract
For substances eliminated from blood by the liver, the effect of a change in unbound fraction of drug (fu b )on steady state total (C b )and unbound (Cu b )blood concentrations has hitherto only been considered for the two limiting cases, i.e., at the upper and lower extremes of hepatic intrinsic clearance (CL int ).For a substance of very low CL int ,if fu b changes, C t will change and Cu b will remain constant, whereas if CL int isvery high, Cu b will change and C b will remain constant.The present study defines the effects of a change in fu b on C b and Cu b over the whole CL int range. Computer simulations were undertaken which predicted that, for a given change in fu b ,absolute and relative changes in C b would decreasenonlinearly with increasing CL int, twhile the relative change in Cu b would increasewith CL int .The absolute change in Cub would be independent of CL int .Significant changes in Cb and Cu b would be observed at intermediate values of CL int not just at the high and low extremes. These theoretical predictions were investigated experimentally in the isolated perfused rat liver by examining the effects of a change in fu b of sodium taurocholate a substance with intermediate CL int (such that at fu b =0.27,hepatic extraction ratio=0.71) induced by concurrent administration of sodium oleate. Sodium 24- 14 C-taurocholate (specific activity 52 μCi/mmol) was infused into the reservoir in a recycling system at 30 μmol/hr for 105 min (n=6). At 45 min a bolus dose of sodium oleate (50 mmol) was administered to the reservoir, followed by a constant infusion of 143 mmol/hr for 1 hr. Following the administration of oleate, taurocholate fu b fell promptly by 55% (0.27–0.12). There was a relative increase of taurocholate C b of 22.7% and a relative decrease in Cu b of 45.4%, in accordance with the simulations (p.This publication has 17 references indexed in Scilit:
- Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: Comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion modelsJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Free Drug Concentration Monitoring in Clinical PracticeClinical Pharmacokinetics, 1986
- Differential Effects of Hypoxia on the Disposition of Propranolol and Sodium Taurocholate by the Isolated Perfused Rat LiverHepatology, 1984
- Importance of Protein Binding for the Interpretation of Serum or Plasma Drug ConcentrationsThe Journal of Clinical Pharmacology, 1982
- Drug interactions involving the displacement of drugs from plasma protein and tissue binding sitesPharmacology & Therapeutics, 1982
- Kinetics of drug-drug interactionsPharmacology & Therapeutics, 1981
- Effect of Salicylic Acid on Pharmacokinetics of Free and Plasma Protein-Bound Bilirubin in Experimental Unconjugated HyperbilirubinemiaJournal of Pharmaceutical Sciences, 1979
- Effect of Sulfisoxazole on Pharmacokinetics of Free and Plasma Protein-Bound Bilirubin in Experimental Unconjugated HyperbilirubinemiaJournal of Pharmaceutical Sciences, 1979
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Binding of sodium taurocholate by bovine serum albuminBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1971